Presentation is loading. Please wait.

Presentation is loading. Please wait.

Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD 

Similar presentations


Presentation on theme: "Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD "— Presentation transcript:

1 Intralesional interferon alfa-2b for refractory, recurrent squamous cell carcinoma of the face 
Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD  Journal of the American Academy of Dermatology  Volume 69, Issue 6, Pages (December 2013) DOI: /j.jaad Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 Recurrent, refractory squamous cell carcinoma (SCC) of the right lip. A, After the ninth recurrence, adjuvant intralesional interferon alfa-2b, 1.5 million U, was injected at multiple sites in the tumor periphery. The injection sites are marked by black dots. B, Twelve months after treatment, an SCC presented outside of the treatment field. There were no recurrences at the site. Journal of the American Academy of Dermatology  , DOI: ( /j.jaad ) Copyright © 2013 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Allison Hanlon, MD, PhD, June Kim, MD, David J. Leffell, MD "

Similar presentations


Ads by Google